Effects of low-level light therapy on hepatic antioxidant defense in acute and chronic diabetic rats

Journal of Biochemical and Molecular Toxicology

Volumn 23, Issue 1, 2009, Pages 1-8

  Lim, Jinhwan ^a   Ali, Zeeshan M ^b   Sanders, Ruth A ^b   Snyder, Ann C ^c   Eells, Janis T ^c   Henshel, Diane S ^a   Watkins III, John B ^b  

^a INDIANA UNIVERSITY   (United States)

^b Indiana University School of Medicine   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Antioxidant enzymes; Hyperglycemia; Liver; Oxidative stress; Photo biomodulation

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PHOTOTHERAPY; RAT; STREPTOZOCIN DIABETES; WISTAR RAT;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; PHOTOTHERAPY; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS;

EID: 59949099120     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20257     Document Type: Article

References (46)

1. Lubart R, Wollman Y, Friedmann H, Rochkind S, Laulicht I. Effects of visible and near-infrared lasers on cell cultures. J Photochem Photobiol B 1992;12:305-310.
2. Eells JT, Henry MM, Summerfelt P, Wong-Riley MT, Buchmann EV, Kane M, Whelan NT, Whelan HT. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci USA 2003;100:3439-3444.
3. Karu T. Low-power laser therapy. In: Tuan Vo-Dinh, editor. Biomedical photonics handbook. Boca Raton, FL: CRC Press; 2003. Ch 48.
4. Lim J, Sanders RA, Yeager RL, Millsap DS, Watkins JB III, Eells JT, Henshel DS. Attenuation of TCDD-induced oxidative stress by 670 nm photobiomodulation in developmental chicken kidney. J Biochem Mol Toxicol 2008; 22:230-239.
5. Desmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MT, Henry MM, Buchmann EV, Connelly MP, Dovi JV, Liang HL, et al. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg 2006;24:121-128.
6. Vladimirov YA, Osipov AN, Klebanov GI. Photobiological principles of therapeutic applications of laser radiation. Biochemistry (Moscow) 2004;69:81-90.
7. Moore PA, Zgibor JC, Dasanayake AP. Diabetes: A growing epidemic of all ages. J Am Dent Assoc 2003;134 Spec No:11S-15S.
8. James WP. The epidemiology of obesity: The size of the problem. J Intern Med 2008;263:336-352.
9. Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 1987;245:243-250.
10. Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 1994;43:676-683.
11. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
12. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004;25:612-628.
13. Watkins JB III, Dykstra TP. Alterations in biliary excretory function by streptozotocin-induced diabetes. Drug Metab Dispos 1987;15:177-183.
14. Stratmann B, Stork I, Tschoepe D. [Diabetic cardiomyopathy - a type of coronary artery disease?]. Internist (Berl) 2008;49:436-440.
15. Yeager RL, Lim J, Millsap DS, Jasevicius AV, Sanders RA, Whelan HT, Watkins JB III, Eells JT, Henshel DS. 670 nanometer light treatment attenuates dioxin toxicity in the developing chick embryo. J Biochem Mol Toxicol 2006;20:271-278.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
17. Tappel AL. Glutathione peroxidase and hydroperoxides. Methods Enzymol 1978;52:506-513.
18. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 1975;250:5475-5480.
19. Crapo JD, McCord JM, Fridovich I. Preparation and assay of superoxide dismutases. Meth Enzymol 1978;53:382-393.
20. Luck H. Catalase. Bergmeryer H-U, editor. Methods of enzyme analysis. New York: Academic Press; 1963. pp 885-888.
21. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
22. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226.
23. Strehler BL. Bioluminescence assay: Principles and practice. Meth Biochem Anal 1968;16:99-181.
24. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
25. Eells JT, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane MP, Gould LJ, Das R, Jett M, Hodgson BD, et al. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion 2004;4:559-567.
26. Wong-Riley MT, Bai X, Buchmann E, Whelan HT. Light- emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons. Neuroreport 2001;12:3033-3037.
27. Cooper CE, Springett R. Measurement of cytochrome oxidase and mitochondrial energetics by near-infrared spec- troscopy. Phil Trans R Soc Lond B: Biol Sci 1997;352:669-676.
28. Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT. Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase. J Biol Chem 2005;280:4761-4771.
29. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
30. Watkins JB III, Noda H. Biliary excretion of organic anions in diabetic rats. J Pharmacol Exp Ther 1986;239:467-473.
31. Bukan N, Sancak B, Yavuz O, Koca C, Tutkun F, Ozcelikay AT, Altan N. Lipid peroxidation and scavenging enzyme levels in the liver of streptozotocin-induced diabetic rats. Indian J Biochem Biophys 2003;40:447-450.
32. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003;17:24-38.
33. Rauscher FM, Sanders RA, Watkins JB III. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15:159-164.
34. Sanders RA, Rauscher FM, Watkins JB III. Effects of quercetin on antioxidant defense in streptozotocin- induced diabetic rats. J Biochem Mol Toxicol 2001;15:143-149.
35. Rauscher FM, Sanders RA, Watkins JB III. Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2000;14:329-334.
36. Rauscher FM, Sanders RA, Watkins JB III. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15:41-46.
37. Saxena AK, Srivastava P, Kale RK, Baquer NZ. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 1993;45:539-542.
38. Lapshina EA, Sudnikovich EJ, Maksimchik JZ, Zabrodskaya SV, Zavodnik LB, Kubyshin VL, Nocun M, Kazmierczak P, Dobaczewski M, Watala C, et al. Antioxidative enzyme and glutathione S-transferase activities in diabetic rats exposed to long-term ASA treatment. Life Sci 2006;79:1804-1811.
39. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 1994;35:177-193.
40. Yu W, Naim JO, McGowan M, Ippolito K, Lanzafame RJ. Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria. Photochem Photobiol 1997;66:866-871.
41. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599-622.
42. Goh SY, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008:93:1143-1452.
43. Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 2003;75:95-108.
44. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002;251:87-101.
45. Zieman SJ, Melenovsky V, Clattenburg L, Corretti MC, Capriotti A, Gerstenblith G, Kass DA. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 2007;25:577-583.
46. Wiernsperger NF. Oxidative stress as a therapeutic target in diabetes: Revisiting the controversy. Diabetes Metab 2003;29:579-585.